NYSE : WRBY
Warby Parker Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 24.59 USD (Oct 30, 2026, 9:39 AM EDT) · Market cap 3.04B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.04B |
| Enterprise Value | 3.00B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 108.24M |
| Shares Outstanding | 123.61M |
| Shares Change (YoY) | +2.77% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 15.67% |
| Owned by Institutions (%) | 96.11% |
| Float | 94.62M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 408.55 |
| Forward PE | 51.07 |
| PS Ratio | 3.34 |
| Forward PS | 2.90 |
| PB Ratio | 7.75 |
| P/TBV Ratio | 7.76 |
| P/FCF Ratio | 139.89 |
| P/OCF Ratio | 31.90 |
| PEG Ratio | 2.01 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 387.54 |
| EV / Sales | 3.29 |
| EV / EBITDA | 72.35 |
| EV / EBIT | n/a |
| EV / FCF | 137.97 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.27 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 2.99 |
| Debt / FCF | 11.54 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 2.06% |
| Return on Assets (ROA) | -1.02% |
| Return on Invested Capital (ROIC) | -2.78% |
| Return on Capital Employed (ROCE) | -1.97% |
| Weighted Average Cost of Capital (WACC) | 13.85% |
| Revenue Per Employee | $225,869 |
| Profits Per Employee | $1,918 |
| Employee Count | 4,036 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 10.01 |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.17M |
| Effective Tax Rate | 21.85% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +22.74% |
| 50-Day Moving Average | 25.14 |
| 200-Day Moving Average | 25.16 |
| Relative Strength Index (RSI) | 45.93 |
| Average Volume (20 Days) | 2,606,832 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 20.50M |
| Short Previous Month | 17.62M |
| Short % of Shares Out | 16.59% |
| Short % of Float | 21.67% |
| Short Ratio (days to cover) | 5.88 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 911.61M |
| Gross Profit | 484.23M |
| Operating Income | -12.00M |
| Pretax Income | 9.91M |
| Net Income | 7.74M |
| EBITDA | 41.47M |
| EBIT | -12.00M |
| Earnings Per Share (EPS) | $0.06 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 292.67M |
| Total Debt | 250.98M |
| Net Cash | 41.70M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 391.99M |
| Book Value Per Share | 3.18 |
| Working Capital | 207.36M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 95.36M |
| Capital Expenditures | -73.61M |
| Depreciation & Amortization | 53.47M |
| Net Borrowing | n/a |
| Free Cash Flow | 21.75M |
| FCF Per Share | $0.18 |
Margins
| Measure | Value |
|---|
| Gross Margin | 53.12% |
| Operating Margin | -1.32% |
| Pretax Margin | 1.09% |
| Profit Margin | 0.85% |
| EBITDA Margin | 4.55% |
| EBIT Margin | -1.32% |
| FCF Margin | 2.39% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.77% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.24% |
| FCF Yield | 0.71% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $31.00 |
| Price Target Difference | 25.97% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 20.79% |
| EPS Growth Forecast (3Y) | 58.46% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.87 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |